Quanterix (QTRX) vs RxSight (RXST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
RxSight (RXST) has outperformed Quanterix (QTRX) over the past year, losing 42.0% versus a loss of 46.5%. Over five years, RXST leads with a -64.6% price change compared with -93.8% for QTRX. RxSight is the larger company by market cap ($201.7 million vs $151.8 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QTRX | RXST |
|---|---|---|
| Share price | $3.21 | $4.85 |
| Market cap | $151.81M | $201.73M |
| 1-day change | -3.46% | +1.04% |
| YTD return | -49.53% | -53.93% |
| 1-year return | -46.50% | -42.03% |
| 5-year return | -93.79% | -64.60% |
| EPS (TTM) | $-2.61 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.77 | $13.22 |
| 52-week low | $2.15 | $4.48 |
| Distance from 52-week high | -63.40% | -63.31% |
| Analyst consensus | none | none |
| Avg. price target upside | -6.54% | +56.08% |
| Average volume | 762.14K | 861.57K |
| Shares outstanding | 47.29M | 41.59M |
| Employees | 450 | 461 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Quanterix in Industrials and RxSight in Health Care.
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
About RxSight
RXST stock →RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
Health Care · Ophthalmic Goods · 461 employees
QTRX vs RXST FAQ
Which is bigger, Quanterix or RxSight?
RxSight (RXST) is larger, with a market capitalization of $201.73M compared with $151.81M for Quanterix (QTRX).
Which stock has performed better over the past year, QTRX or RXST?
RXST returned -42.03% over the past 12 months, compared with -46.50% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Quanterix and RxSight in the same industry?
No. Quanterix is in the Industrials sector, while RxSight is in Health Care.